Clinical Studies Fund 2019
In keeping with the goals of the ECVIM-CA and the generosity of our sponsors, we have created a Clinical Studies Fund 2019, whose aim is to encourage research and other contributions to knowledge relating to the pathogenesis, diagnosis, therapy, prevention, and control of diseases directly or indirectly affecting the internal organs of companion animals in Europe.
The goal of the fund is to support the highest-calibre clinical research of relevance to companion animals in Europe. Applications from outside Europe will also be considered, but priority will be given to studies in which at least one of the applicants is based within a European place of work. We encourage multi-centred studies. The Principal Investigator should be a Diplomate of the relevant European, American or Australasian College, or a Diplomate in training under the supervision of a Diplomate.
Only clinical projects that do not involve invasive or harmful procedures will be considered. An expert panel will review all proposals according to a common list of objective criteria and funding will be granted solely on scientific merit and availability of funding, after ranking the proposals accordingly.
Deadline for applications: 17:00 GMT on 3rd June 2019.
The maximum amount available to split between projects in 2019 is 60,000 €
Funding decision: Applicants will be informed of the reviewers’ decision by: 5th August 2019.
Each Diplomate or Diplomate in training may submit one application (one electronic copy), which should be typed in Arial font 11 point and double-spaced, numbering consecutive pages from the Cover Page (page 1).
Applications should be succinct and comprise (sub-section headings italicized):
1. A Cover Page with research title, investigators and affiliations.
2. An Abstract (not more than 300 words)
3. An Introduction and Scientific Background (not more than 400 words)
4. An account of the Contribution of the Project to Companion Animal Internal Medicine in Europe (not more than 400 words)
5. A detailed description of the Research Plan, including a sub-section entitled Hypothesis and SMART Objectives (not more than 1000 words)
6. References (maximum of 40)
7. Budget details, including a sub-section entitled Justification (not more than 400 words)
8. Timeline (not more than 300 words)
9. Curricula Vitae of the principal and all co-investigators (not more than two pages per investigator)
Please note that applications not adhering to these formatting guidelines will be rejected without further consideration. Please also note that we will NOT review projects under consideration by alternative funding bodies. Thank you.
Clinical Studies Fund Downloads
The ECVIM-CA is deeply indebted to the following contributors to our "ECVIM Clinical Studies Fund".
Clinical Studies Fund Committee
- Professor Oliver Garden (Internal Medicine), University of Pennsylvania, USA (Chair)
- Professor Alexander German (Internal Medicine), University of Liverpool, UK
- Dr Monica Augusto (Internal Medicine), University College Dublin, Ireland
- Dr Itamar Aroch (Internal Medicine), Hebrew University of Jerusalem, Israel
- Dr Kristin Anfinsen (Internal Medicine), University of Oslo, Norway
- Dr David Killick (Oncology), University of Liverpool, UK
- Professor Lisbeth Olsen (Cardiology), University of Copenhagen, Denmark